¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phase curve"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • plane curve
    Æò¸é°î¼±
  • polar curve
    ±ØÁÂÇ¥°î¼±
  • preponderance curve
    ¿ì¼¼°î¼±
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±
  • probability curve
    È®·ü°î¼±
  • pulse curve
    ¸Æ¹Ú°î¼±
  • percentage depth dose curve
    ½ÉºÎ¼±·®¹éºÐÀ²°î¼±
  • quadratic curve
    ÀÌÂ÷°î¼±
  • receiver operating characteristic curve
    ¼ö½Å±âÀÛµ¿Æ¯¼º°î¼±
  • regression curve
    ȸ±Í°î¼±
  • response curve
    ¹ÝÀÀ°î¼±
  • solubility curve
    ¿ëÇØµµ°î¼±
  • stiffness curve
    °æÁ÷µµ°î¼±, °­Á÷µµ°î¼±
  • strength duration curve
    °­µµ±â°£°î¼±
  • survival curve
    »ýÁ¸°î¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • percentage depth dose curve
    ½ÉºÎ¼±·®¹éºÐÀ²°î¼±
  • plane curve
    Æò¸é°î¼±
  • polar curve
    ±ØÁÂÇ¥°î¼±
  • preponderance curve
    ¿ì¼¼°î¼±
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±
  • probability curve
    È®·ü°î¼±
  • pulse curve
    ¸Æ¹Ú°î¼±
  • quadratic curve
    ÀÌÂ÷°î¼±
  • receiver operating characteristic curve
    ¼ö½Å±âÀÛµ¿Æ¯¼º°î¼±
  • regression curve
    ȸ±Í°î¼±
  • response curve
    ¹ÝÀÀ°î¼±
  • sensitometric curve
    °¨±¤µµ°è°î¼±
  • shadow curve
    À½¿µ°î¼±
  • sigmoid dose-response curve
    ±¸ºÒ¼±·®¹ÝÀÀ°î¼±
  • single-step growth curve
    ÀÏȸÁõ½Ä°î¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • in-phase image
    À§»ó³» ¿µ»ó
  • inactive phase
    ºñȰµ¿±â
  • inadequate luteal phase
    Ȳü±âºÎÀü(üÜô÷ÐïÝÕîï).
  • inadequate luteal phase
    Ȳü±âºÎÀü(üÜô÷ÐïÝÕîï).
  • inspiratory phase
    Èí±â»ó(ýåѨßÓ).
  • inspiratory phase time
    Èí±â»ó½Ã°£.
  • phallic stage (phase)
    ³²±Ù±â(ÑûÐÆÑ¢).
  • phase
    »ó, ±â
  • phase
    ˤȗ
  • phase 1 study
    ÀÓ»óÁ¦1»ó½ÃÇè.
  • phase I block
    Á¦1»óÂ÷´Ü.
  • phase advance
    »óÀüÁø(ßÓîñòä)
  • phase angle
    À§»ó°¢(êÈßÓÊÇ).
  • phase angle
    À§»ó °¢
  • phase artifact
    À§»ó Àΰø¹°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • epidemic curve
    À¯Çິ(Àü¿°º´)°î¼±
  • epidemic curve
    À¯Çà°î¼±.
  • equal loudness curve
    À½·®µî°¨°î¼±(ËôËâËÄ˧˭ËÛ).
  • equal loudness curve
    À½·®µî°¨°î¼±(ëååÖÔõÊïÍØàÊ).
  • equidistant curve
    µî°Å¸®°î¼±.
  • exponential curve
    Áö¼ö°î¼±.
  • extension curve
    ½ÅÀü °î¼±(ãßî÷ÍØàÊ).
  • fatigue curve
    ÇǷΰ(¡­ÍØàÊ).
  • flow volume curve
    À¯·®¿ë·®°î¼±(êüÕáé»ÕáÍØàÊ).
  • flow-volume curve
  • fluid velocity curve
    À¯¼Ó °î¼±
  • frenquency response curve
    Á֯ļö ¹ÝÀÀ°î¼±
  • frequency curve
    µµ¼ö°î¼±
  • frequency curve
    µµ¼ö°î¼±(̬ËàË­ËÛ).
  • frequency distribution curve
    µµ¼öºÐÆ÷°î¼±
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • phase contrast microscope
    À§»óÂ÷(êÈßÓó¬) Çö¹Ì°æ(ßÓÓßðÎúéÚ°Ìð)
  • phase partition
    »óºÐ¹è(ßÓÝÂÛÕ)
  • phase plate
    »óÆÇ(ßÓ÷ù)
  • phase rule
    »óÀ²(ßÓëÏ)
  • phase shift mutation
    »óÀ̵¿ º¯ÀÌ(ßÓì¹ÔÑܨì¶)
  • phase test
    »ó½ÃÇè(ßÓãËúÐ)
  • phase transfer
    »óÀüÀÌ(ßÓï®ì¹)
  • phase variation
    »óº¯µ¿(ßÓܨÔÑ)
  • preinductive phase
    ÀüÀ¯µµ±â(îñë¯ÓôÑ¢)
  • productive phase
    »ý»ê±â(ßæß§Ñ¢)
  • reduction phase
    ȯ¿ø±â(ü½êªÑ¢)
  • regeneration phase
    Àç»ý±â(î¢ßæÑ¢)
  • reversed phase chromatography
    ¿ª»ó(æ½ßÓ) Å©·Î¸¶Åä±×·¡ÇÇ
  • solid phase synthesis
    °í»óÇÕ¼º(ͳßÒùêà÷)
  • stationary phase
    "Á¤Áö»ó(ïÎò­ßÓ), Á¤Áö±â(ïÎò­Ñ¢)"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • phase wraparound artifact
    À§»óÆ÷ÀåÀΰø¹°
  • portal phase
    ¹®¸Æ±â
  • respiratory ordered phase encoding
    È£Èí¼øÀ§»óºÎȣȭ
  • resting phase
    È޽ıâ
  • spin phase
    ½ºÇÉÀ§»ó
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • test phase
    ½ÃÇè±â
  • venous phase
    Á¤¸Æ»ó, Á¤¸Æ±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
P-V pressure-volume [curve]
TAC tachykinin; terminal antrum contraction; tetracaine, adrenalin, and cocaine; time-activity curve; to...
VFC ventricular function curve
LPD Luteal Phase Defect
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ROC Receiver Operating Characteristic Curve
ROC Receiver Operating Curve
ROC Receiver Operator Characteristic Curve
ROC Receiver Operator Curve
TAC Time activity curve
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • arterial phase
    µ¿¸Æ ±â
  • bacterial phase
    ¼¼±Õ »ó
    ¼¼±ÕÀÌ ´«¿¡ º¸ÀÌ´Â ¾ç»ó.
  • closing phase
    Æó±¸ ´Ü°è
  • dispersed phase
    ºÐ»ê »ó
  • equilibrium phase diagram
    ÆòÇü »óŵµ
    ÇÕ±ÝÀÇ Á¶¼º°ú ¿Âµµ°¡ ¹Ù²î¾îÁ³À» ¶§ÀÇ ÆòÇü »óÅ¿¡¼­ÀÇ »óÀÇ º¯È­¸¦ º¸ÀÎ ±×¸².
  • expiratory phase
    È£±â
  • exponential phase of growth
    ´ë¼ö Áõ½Ä±â, °¡¼Ó ¼ºÀå±â
  • implant surgical phase
    ¸Å½Ä ¿Ü°úÀû ´Ü°è
    ¸Å½Ä ÀÇÄ¡¸¦ Á¦ÀÛÇϱâ À§ÇÏ¿© Á¦1´Ü°èÀû »óÅ·Î, °ñ¸·À» ¾Ç°ñ¿¡¼­ ºÐ¸®ÇÏ¿© °ñ¸·ÀÌ ³ëÃâµÈ »óÅÂÀε¥ ¿©±â¼­ ÀλóÀÌ Ã¤µæµÈ´Ù. Á¦ 2´Ü°è´Â ±× °ñ¸é¿¡ ±Ý¼Ó ¸Å½Ä¹°À» ³õ°í ´Ù½Ã ºÀÇÕÇÏ¿© ¸Å½Ä¹°ÀÇ Áö´ëÄ¡°¡ ¿ÜºÎ·Î ³ëÃâµÇµµ·Ï ÇÏ´Â ´Ü°è. ÀÌ»óÀÇ µÎ ´Ü°è¸¦ ÀÏÄ´´Ù.
  • isotonic contraction phase
    µî·Â ¼öÃà±â
  • lactiferous phase
    ¼öÀ¯±â
  • lag phase
    ½Ãµ¿±â
  • late luteal phase dysphoric disorder
    ¸»±â Ȳü±â ºÒÄè Àå¾Ö
  • latency phase
    Àẹ±â
    º´¼Ò°¡ ħÀÔÇØ¼­ Áï½Ã °¨¿°À» ÀÏÀ¸Å°´Â °ÍÀÌ ¾Æ´Ï°í ¼÷ÁÖ ³»¿¡ ±â»ýÇϸ鼭 ÀûÀÀÇØ¼­ °¨¿°ÀÇ Áõ»óÀ» ³ªÅ¸³»±â±îÁöÀÇ ½Ã°£.
  • life phase
    »ýȰ»ó
  • luteal phase
    ¿ù°æ ÁÖ±âÁß È²Ã¼±â, Ȳü ´Ü°è, Ȳü±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
dye-dilution curve Graph of the serial concentrations (dilutions) of a dye, e.g., Evans blue, following its intravascular or intracardiac injection; useful in the diagnosis of congenital cardiac shunts, measurement of cardiac output, and detection of cardiovalvular incompetence.
Synonym: indicator-dilution curve.
(05 Mar 2000)
indicator-dilution curve Graph of the serial concentrations (dilutions) of a dye, e.g., Evans blue, following its intravascular or intracardiac injection; useful in the diagnosis of congenital cardiac shunts, measurement of cardiac output, and detection of cardiovalvular incompetence.
Synonym: indicator-dilution curve.
(05 Mar 2000)
intracardiac pressure curve Curve of pressure recorded within the atrium or ventricle (intra-atrial and intraventricular pressure curve's).
(05 Mar 2000)
isovolume pressure-flow curve The relationship between transpulmonary pressure and respiratory air flow, expressed as a function of lung volume.
(05 Mar 2000)
tension curve The direction of the trabeculae in cancellous bone tissue adapted to resist stress.
(05 Mar 2000)
epidemic curve A graph in which the number of new cases of a disease is plotted against an interval of time to describe a specific epidemic or outbreak.
(05 Mar 2000)
flow-volume curve The graph produced by plotting the instantaneous flow of respiratory gas against the simultaneous lung volume, usually during maximal forced expiration.
(05 Mar 2000)
force-velocity curve The relationship between isotonic velocity of shortening and afterload for a contracting muscle.
(05 Mar 2000)
Frank-Starling curve A graph in which cardiac output or stroke volume is plotted against mean atrial or ventricular end-diastolic pressure; with increasing venous return and atrial pressure the output proportionately increases until further increments overload the heart and the output falls.
Synonym: Frank-Starling curve.
(05 Mar 2000)
frequency curve A systematic grouping of data into classes or categories according to the frequency of occurrence of each successive value or ranges of such values, resulting in a graph of a frequency distribution.
Synonym: frequency curve.
(05 Mar 2000)
Friedman curve A graph on which hours of labour are plotted against cervical dilation in centimeters.
(05 Mar 2000)
logistic curve An S-shaped curve which depicts the growth of a population in an area of fixed limits.
(05 Mar 2000)
accelerated phase of leukaemia Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase.
(12 Dec 1998)
acceleration phase <cell biology, cell culture> A period of increasing growth before the log phase in a culture of microbes.
After the culture is started on a medium, at first there is no growth (the lag phase) and then the microbes start to gradually grow (acceleration phase) until they reach a constant maximum rate of growth (log phase).
(15 Jan 1998)
acute-phase protein <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor).
Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold.
Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability.
These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers.
See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity.
(25 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á